Mendelspod Podcast
The 21st is the Century of Biology. A radical advancement in the knowledge of basic biology and human disease is transforming our world. We interview the heroes beneath the headlines.
- Update frequency
- every 5 days
- Average duration
- 27 minutes
- Episodes
- 503
- Years Active
- 2014 - 2025
Reinventing PCR: Pranav Patel, N6 Tec
Reinventing PCR, huh? That’s what we asked Pranav Patel, CEO and co-founder of N6 Tec, on today’s show. After all, PCR is one of the oldest tools in the molecular biology toolbox. Isn’t that field… d…
Making Whole Genome Sequencing the Universal Genetic Test - with David Ledbetter, Pediatric Rare Disease Institute, FSU
Today we sit down with renowned geneticist David Ledbetter, whose pioneering work helped uncover the chromosomal basis of Prader-Willi, Angelman, and Miller-Dieker syndromes. He served as Chief Scien…
Remembering Atul Butte with Marina Sirota, Chirag Patel and Mike Snyder
In this special tribute episode, Mendelspod honors the life and legacy of Dr. Atul Butte (1969-2025), a towering figure in big data and precision medicine who passed away earlier this year. Atul was …
The Age of Digital Pathology with Andy Beck, PathAI
Most cancer biomarkers aren’t found in your DNA—they’re found on a microscope slide. And according to Dr. Andy Beck, CE…
What’s New for Regulatory Informatics in the Age of AI? Not Much—And That’s the Point with Raju Rayavarapu of DNAnexus
In this episode of Mendelspod, we’re joined by Raju Rayavarapu, bioinformatician at DNAnexus and former FDA data specialist, to discuss how regulatory science is adapting to the age of AI, big data, …
From Illumina to Advocacy: Mike Kreitzinger on the Future of Clinical Genomics
“Genomics works. Don’t be scared of it.” That’s the message from Mike Kreitzinger, a longtime Illumina leader now advis…
Amplifying the Expert: Jing Gao on Illumina's Connected Insights
Illumina’s new interpretation software, Illumina Connected Insights, signals a turning point in oncology genomics—where sequencing power meets end-to-end clinical utility. On this episode of Mendelsp…
The End of Animal Testing? Vivodyne Scales Human Tissue with CEO Andrei Georgescu
Can we finally replace animal testing in drug development—and still know a drug is safe and effective?
That’s the provoc…
How Liquid Biopsy Is Becoming Standard of Care with Rita Shaknovich, CMO, Agilent
In this episode of Mendelspod, Theral welcomes Dr. Rita Shaknovich, Chief Medical Officer in Agilent’s Life Sciences and Diagnostics group, for a high-level and deeply insightful look at where liquid…
Tracking GMOs in the Gene Editing Era: Frédéric Debode on the Science of GMO Detection
In this episode of Mendelspod, Theral speaks with Frédéric Debode, Scientific Director at CRA-W in Wallonia, Belgium, about the evolving landscape of GMO detection in the age of gene editing. From ea…
From Discovery to Translation: Bruker's Bold New Play in Spatial with Joe Beechem and Oliver Braubach
“We’re going to be rewriting the textbooks on how tissues work.”
In this compelling reunion with spatial biology pioneer Joe Beechem and a first-time visit from Oliver Braubach, we explore the rapid e…
Tagomics Wins NHS Grant, Unveils De-Methylation Platform for Early Cancer Testing with Rob Neely, CSO
In this episode of Mendelspod, Theral sits down with Rob Neely, co-founder and CSO at Tagomics, to discuss how his comp…
From Paris to the Pentagon: Sophie Peresson Maps Biosecurity’s New Landscape
In this premium episode of Mendelspod, we’re joined by one of the few people speaking clearly and globally about biosec…
From Mitochondria to Protein Degradation: Mike Kiebish on BPGbio’s "Biology First" Vision
As artificial intelligence continues to influence the life sciences, some researchers are questioning not just what it …
The Grammar of RNA: Gavin Knott on Gene Editing and Structural Biology in the Age of AI
In this episode of Mendelspod, we plunge into the shape-shifting world of RNA with Dr. Gavin Knott, associate professor at Monash University and alum of Jennifer Doudna’s lab. Knott is part of a new …
The Third Way: Christian Schafmeister’s Spiroligomer Revolution
For decades, drug discovery has followed two main roads: small molecules that can slip into cells but often lack precis…
Can Math and AI Replace Some Biology in Drug Discovery? with Aridni Shah, Immunito AI
What if drug design didn’t depend on pre-existing biological data?
In this episode of Mendelspod, Theral sits down with Aridni Shah, co-founder and CEO of Immunito AI, a Bengaluru-based biotech start…
$10 Genome, $8 Coffee: Rethinking the Economics of Life Science Tools with Stephane Budel, DeciBio
Yes, the Trump economy has been tough on life science tools—but according to today’s guest, the business model was fail…
Quantum Scale: A New Era for Single-Cell Analysis with Giovanna Prout
On today’s episode of Mendelspod, Theral sits down with Giovanna Prout, CEO of Scale Biosciences, to explore a how the…
Building Intuition at the Nanoscale: Steve McCloskey of Nanome on the VR Future of Science
What if you could step inside a molecule? On today’s episode of Mendelspod, we talk with Steve McCloskey, founder and CEO of Nanome, the company bringing virtual reality into the world of drug discov…